Intracoronary bivalirudin: a new way to appease the hostile thrombus?
暂无分享,去创建一个
I. Porto | A. Rognoni | G. Secco | A. Lupi | M. Lazzero | A. S. Bongo | G. Genoni | R. Parisi
[1] A. Weintraub,et al. Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention , 2011, Circulation. Cardiovascular interventions.
[2] H. Hillege,et al. Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration: The Comparison of Intracoronary Versus Intravenous Abciximab Administration During Emergency Reperf , 2010, Circulation.
[3] R. Kloner,et al. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. , 2010, Journal of interventional cardiology.
[4] B. Cortese,et al. Intracoronary bivalirudin for no reflow reversal: a second chance to treat this disorder? , 2009, Journal of Thrombosis and Thrombolysis.
[5] Michail I. Papafaklis,et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. , 2007, Journal of the American College of Cardiology.
[6] O. Topaz. Revascularization of thrombus-laden lesions in AMI--the burden on the interventionalist. , 2007, The Journal of invasive cardiology.
[7] A. M. Leone,et al. Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions. , 2007, The Journal of invasive cardiology.
[8] O. Topaz. On the hostile massive thrombus and the means to eradicate it , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] R. Gibbons,et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. , 2005, JAMA.
[10] H. Hod,et al. Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction , 2004, Circulation.
[11] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[12] J. Ornato,et al. Patients with Coronary Artery Disease who Present with Chest Pain Have Significantly Elevated Platelet Contractile Force and Clot Elastic Modulus , 2002, Thrombosis and Haemostasis.
[13] K. Okumura,et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[14] L. Harker,et al. Strategies for inhibiting the effects of thrombin , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[15] T. Fischell,et al. Evidence for altered epicardial coronary artery autoregulation as a cause of distal coronary vasoconstriction after successful percutaneous transluminal coronary angioplasty. , 1990, The Journal of clinical investigation.
[16] B. Uretsky,et al. Thrombus aspiration during primary percutaneous coronary intervention. , 2008, The New England journal of medicine.
[17] L. Becker. Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.